Tenax Therapeutics (TENX) Long-Term Deferred Tax (2015 - 2020)

Tenax Therapeutics' Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $347.0 for Q4 2020.

• In Q4 2020, Long-Term Deferred Tax fell 96.05% year-over-year to $347.0; the TTM figure through Dec 2020 stood at $347.0 (down 96.05% YoY), while the FY2020 annual figure was $347.0, down 96.05% from the prior year.
• Long-Term Deferred Tax came in at $347.0 for Q4 2020 at Tenax Therapeutics, down from $8775.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $56180.0 in Q4 2016 to a low of $347.0 in Q4 2020.
• A 5-year average of $23871.8 and a median of $12732.0 in 2018 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax soared 193.35% in 2016 and plunged 96.05% in 2020, its largest moves.
• Tenax Therapeutics' Long-Term Deferred Tax stood at $56180.0 in 2016, then dropped by 26.44% to $41325.0 in 2017, then slumped by 69.19% to $12732.0 in 2018, then plunged by 31.08% to $8775.0 in 2019, then slumped by 96.05% to $347.0 in 2020.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $347.0, $8775.0, and $12732.0 for Q4 2020, Q4 2019, and Q4 2018 respectively.

Peer Comparison